Skip to main content
Log in

An objective evaluation of once-daily sustained-release verapamil (480 mg) in chronic stable angina

  • Letters To The Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Bala Subramanian V, Bowles MJ, Lahiri A, Davies AB, Raftery EB (1981) Long-term antianginal action of verapamil assessed using quantitated serial treadmill stress testing. Am J Cardiol 48: 529–535

    Google Scholar 

  2. Bala Subramanian V, Bowles MJ, Khurmi NS, Davies AD, Raftery EB (1982) A randomised double-blind comparison of verapamil and nifedipine in chronic stable angina. Am J Cardiol 50: 696–703

    Google Scholar 

  3. Norris RJ, Muirhead DC, Christie RB, Devan JG, Bottini PB (1985) The bio-availability of a slow-release verapamil formulation. Br J Clin Pract 39 [Suppl 42]: 9–15

    Google Scholar 

  4. Kohli RS, Rodrigues EA, Hughes LO, Lahiri A, Raftery EB (1987) Sustained release verapamil, a once-daily preparation: Objective evaluation using exercise testing, ambulatory monitoring and blood levels in patients with stable angina. J Am Coll Cardiol 9: 615–621

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rodrigues, E.A., DasGupta, P., Hains, A.D.B. et al. An objective evaluation of once-daily sustained-release verapamil (480 mg) in chronic stable angina. Eur J Clin Pharmacol 34, 531–532 (1988). https://doi.org/10.1007/BF01046717

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01046717

Key words

Navigation